US Companies Launch CRISPR Clinical Trial
US Companies Launch CRISPR Clinical Trial
The Germany-based study will test an ex vivo genome-editing therapy for the inherited blood disorder β-thalassemia.
US Companies Launch CRISPR Clinical Trial
US Companies Launch CRISPR Clinical Trial

The Germany-based study will test an ex vivo genome-editing therapy for the inherited blood disorder β-thalassemia.

The Germany-based study will test an ex vivo genome-editing therapy for the inherited blood disorder β-thalassemia.

sickle cell anemia
Charting Crescents, 1910
Charting Crescents, 1910
Sukanya Charuchandra | Oct 1, 2018
James Herrick, a Chicago doctor, was the first to describe sickled red blood cells in a patient of African descent.
More Success Fixing Sickle Cell Gene with CRISPR
More Success Fixing Sickle Cell Gene with CRISPR
Kerry Grens | Nov 9, 2016
Researchers say they have sufficient in vitro and animal data to apply for human testing.
CRISPR Corrects Sickle Cell-Causing Gene in Human Cells
CRISPR Corrects Sickle Cell-Causing Gene in Human Cells
Kerry Grens | Oct 13, 2016
Once implanted in mice, the edited stem cells produced normal hemoglobin.
How Blood Cells Thwart Malaria
Tia Ghose | Nov 10, 2011
The sickle cell anemia mutation may protect against malaria by preventing the parasite from sending dangerous proteins to the red blood cell surface.